Zobrazeno 1 - 10
of 100
pro vyhledávání: '"Feliciano, Barrón"'
Autor:
Luis A. Cabrera-Miranda, Diego A. Díaz-García, José F. Corona-Cruz, Francisco J. Lozano-Ruiz, Roberto Sánchez-Reyes, Mario E. Álvarez-Bojórquez, Mónica Blake-Cerda, Raúl Rivera-Márquez, Raúl A. López-Saucedo, Sandra I. Pérez-Álvarez, Laura M. Bolaño-Guerra, Jorge A. Alatorre-Alexander, Francisco Alexander-Meza, Feliciano Barrón-Barrón, Yazmin C. Blanco-Vázquez, Saúl Campos-Gómez, Dolores de la Mata-Moya, Pedro Figueroa-Martínez, Paulina E. González-Cisneros, Marco A. Iñíguez-García, Jesús M. Lázaro-León, Ulises Loyola-García, Marcelino Morales-Rivera, Carlos Olivares-Torres, Maritza Ramos-Ramírez, Julia A. Sáenz-Frías, Fernando Silva-Bravo, Rogelio Trejo-Rosales, Miguel Souto-del Bosque, Óscar Arrieta
Publikováno v:
Gaceta Mexicana de Oncología, Vol 22, Iss 2 (2023)
Antecedentes: El cáncer de células pequeñas (CPCP) representa el 13-15% del total de neoplasias primarias de pulmón. Se caracteriza por su rapidez en la tasa de crecimiento y en el desarrollo de metástasis a distancia. Objetivos: Orientar y esta
Externí odkaz:
https://doaj.org/article/b4bb4b989e5042dda4dde5de684837ce
Autor:
Pamela Soberanis Pina, Luis Lara-Mejía, Venecia Matias-Cruz, Feliciano Barrón, Andrés F. Cardona, Luis E. Raez, Eduardo Rios-Garcia, Oscar Arrieta
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Lung cancer (LC) is one of the most common causes of death worldwide. The identification of oncogene-addicted driving mutations suitable for targeted therapy has improved clinical outcomes in advanced diseases. Clinical trials, on the other hand, rar
Externí odkaz:
https://doaj.org/article/97f458914fea497dbd8b05ee52644cbf
Autor:
Claudio Martín, Diego Enrico, Luis Mas, Ana Karina Patane, Oscar Arrieta, Tannia Soria, Andrés F. Cardona, Alejandro Ruiz‐Patiño, Rossana Ruiz, Patricia Rioja, Sophia Lozano, Zyanya Lucia Zatarain‐Barrón, Feliciano Barrón, Carmen Puparelli, Florencia Tsou, Marcelo P. Corassa, Helano C. Freitas, Vladmir Cláudio Cordeiro de Lima, Leonardo Rojas, Camila Ordóñez‐Reyes, Luis Corrales, Carolina Sotelo, July Rodríguez, Luisa Ricaurte, Jenny Ávila, Pilar Archila, Rafael Rosell, Mauricio Cuello, Jordi Remon, CLICaP
Publikováno v:
Thoracic Cancer, Vol 12, Iss 9, Pp 1328-1335 (2021)
Abstract Background Thymomas are a group of rare neoplasms of the anterior mediastinum. The objective of this study was to describe the demographics, clinical characteristics and treatment approaches in Latin America. Methods This was a retrospective
Externí odkaz:
https://doaj.org/article/fb62b243facb450393a23abb333ccdf6
Autor:
Alejandro Ruiz-Patiño, Oscar Arrieta, Luis E. Pino, Christian Rolfo, Luisa Ricaurte, Gonzalo Recondo, Zyanya-Lucia Zatarain-Barron, Luis Corrales, Claudio Martín, Feliciano Barrón, Carlos Vargas, Hernán Carranza, Jorge Otero, July Rodriguez, Carolina Sotelo, Lucia Viola, Alessandro Russo, Rafael Rosell, Andrés F. Cardona
Publikováno v:
JCO Global Oncology, Vol , Iss 6, Pp 752-760 (2020)
PURPOSE In the midst of a global pandemic, evidence suggests that similar to other severe respiratory viral infections, patients with cancer are at higher risk of becoming infected by COVID-19 and have a poorer prognosis. METHODS We have modeled the
Externí odkaz:
https://doaj.org/article/190fa5ee9d6a40a7a6e1a4e4cdef9392
Autor:
Alejandro Ruiz‐Patiño, Feliciano Barrón, Andrés F. Cardona, Luis Corrales, Luis Mas, Claudio Martín, Zyanya L. Zatarain‐Barrón, Gonzalo Recondo, Luisa Ricaurte, Leonardo Rojas, Pilar Archila, July Rodríguez, Carolina Sotelo, Lucia Viola, Carlos Vargas, Hernán Carranza, Jorge Otero, Luis E. Pino, Christian Rolfo, Rafael Rosell, Oscar Arrieta, The CLICaP
Publikováno v:
Thoracic Cancer, Vol 11, Iss 9, Pp 2552-2560 (2020)
Background The intestinal microbiota is an important factor in modulating immune‐mediated tumor cell destruction. Alterations in the microbiome composition have been linked to reduced efficacy of immune checkpoint inhibitor (ICI) therapies. Therefo
Externí odkaz:
https://doaj.org/article/e1816c0c556f4d82a0133d98cf0baf9e
Autor:
Oscar Arrieta, Rodrigo Catalán, Silvia Guzmán-Vazquez, Feliciano Barrón, Luis Lara-Mejía, Herman Soto-Molina, Maritza Ramos-Ramírez, Diana Flores-Estrada, Jaime de la Garza
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Tyrosine-kinase inhibitors (TKIs) have become the cornerstone treatment of patients with non-small cell lung cancer that harbor oncogenic EGFR mutations. The counterpart of these drugs is the financial burden that they impose, whi
Externí odkaz:
https://doaj.org/article/a271e89161d143bbbc8a2934bd76b46f
Autor:
Andrés F. Cardona, Alejandro Ruiz-Patiño, Luisa Ricaurte, Zyanya Lucia Zatarain-Barrón, Feliciano Barrón, Oscar Arrieta
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 1, Pp 314-320 (2020)
Due to the widespread use of immune checkpoint inhibitors and the growing research efforts in this area, immune-mediated toxicity is well recognized. Nonetheless, few severe cases of oral or upper gastrointestinal tract mucosal involvement have been
Externí odkaz:
https://doaj.org/article/a5453f3fc05a43a090e0fd918a71d16a
Autor:
Alejandro Ruiz‐Patiño, Oscar Arrieta, Andrés F. Cardona, Claudio Martín, Luis E. Raez, Zyanya L. Zatarain‐Barrón, Feliciano Barrón, Luisa Ricaurte, María A. Bravo‐Garzón, Luis Mas, Luis Corrales, Leonardo Rojas, Lorena Lupinacci, Florencia Perazzo, Carlos Bas, Omar Carranza, Carmen Puparelli, Manglio Rizzo, Rossana Ruiz, Christian Rolfo, Pilar Archila, July Rodríguez, Carolina Sotelo, Carlos Vargas, Hernán Carranza, Jorge Otero, Luis E. Pino, Carlos Ortíz, Paola Laguado, Rafael Rosell, on behalf of the CLICaP
Publikováno v:
Thoracic Cancer, Vol 11, Iss 2, Pp 353-361 (2020)
Background To compare survival outcomes of patients with advanced or metastatic non‐small cell lung cancer (NSCLC) who received immunotherapy as first‐, second‐ or beyond line, versus matched patients receiving standard chemotherapy with specia
Externí odkaz:
https://doaj.org/article/6b5eafa8845147498983649ec3646492
Autor:
Alejandro Ruiz-Patiño, July Rodríguez, Andrés F. Cardona, Jenny Ávila, Pilar Archila, Hernán Carranza, Carlos Vargas, Jorge Otero, Oscar Arrieta, Lucia Zatarain-Barrón, Carolina Sotelo, Camila Ordoñez, Juan Esteban García-Robledo, Leonardo Rojas, Maritza Bermúdez, Tatiana Gámez, Diana Mayorga, Luis Corrales, Claudio Martín, Gonzalo Recondo, Luis Mas, Suraj Samtani, Luisa Ricaurte, Umberto Malapelle, Alessandro Russo, Feliciano Barrón, Nicolas Santoyo, Christian Rolfo, Rafael Rosell
Publikováno v:
Translational Oncology, Vol 15, Iss 1, Pp 101276- (2022)
Background: The KRAS exon 2 p. G12C mutation in patients with lung adenocarcinoma has been increasing in relevance due to the development and effectiveness of new treatment medications. Studies around different populations indicate that regional vari
Externí odkaz:
https://doaj.org/article/dea50884219f4b58aada2eb1e72a93c5
Autor:
Alessandro Russo, Christian Rolfo, Andrés Cardona, Aung Naing, Rivka Colen, Christine Peterson, Diego de Miguel Perez, Muthukumar Gunasekaran, Vincenzo Adamo, Oscar Arrieta, Feliciano Barrón, Luis Lara-Mejía, Philip Mack, Fred Hirsch
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/56b5b8b57e944be291f269ed6586c2b9